Hop
Homeodynamics (HOP Tech) is a company transforming precision medicine by developing adaptive digital biomarkers for drug development and clinical trials. Their platform utilizes high-resolution, non-invasive sensors (electrodermal response, photonic response, pneumo acoustic) to capture a patient's 'in-motion' body response signature. This data, combined with multi-level labeling strategies and advanced AI/machine learning, enables faster and more effective clinical trials, particularly in areas like type 2 diabetes, heart failure, and oncology. HOP Tech's approach is endorsed by top pharmaceutical companies and academic institutions, aiming to provide surrogate-grade endpoints and accelerate the delivery of groundbreaking medical solutions.
Hop
Homeodynamics (HOP Tech) is a company transforming precision medicine by developing adaptive digital biomarkers for drug development and clinical trials. Their platform utilizes high-resolution, non-invasive sensors (electrodermal response, photonic response, pneumo acoustic) to capture a patient's 'in-motion' body response signature. This data, combined with multi-level labeling strategies and advanced AI/machine learning, enables faster and more effective clinical trials, particularly in areas like type 2 diabetes, heart failure, and oncology. HOP Tech's approach is endorsed by top pharmaceutical companies and academic institutions, aiming to provide surrogate-grade endpoints and accelerate the delivery of groundbreaking medical solutions.